Androgens and metabolic syndrome: Lessons from androgen receptor knock out (ARKO) mice

Journal of Steroid Biochemistry and Molecular Biology

Volumn 109, Issue 3-5, 2008, Pages 254-257

  Yanase, Toshihiko ^a   Fan, WuQiang ^a   Kyoya, Kanako ^a   Min, Liu ^a   Takayanagi, Ryoichi ^a   Kato, Shigeaki ^b   Nawata, Hajime ^c  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Androgen receptor; Gene knockout; Obesity; Thermogenesis

Indexed keywords

ANDROGEN RECEPTOR; SELECTIVE ANDROGEN RECEPTOR MODULATOR; TESTOSTERONE; UNCOUPLING PROTEIN 1;

ADIPOCYTE; ANDROGEN METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; INSULIN SENSITIVITY; LIPOLYSIS; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; PROSTATE CANCER;

ADIPOCYTES; AGE DISTRIBUTION; ANDROGENS; ANIMALS; CELL DIFFERENTIATION; HUMANS; METABOLIC DISEASES; MICE; MICE, KNOCKOUT; RECEPTORS, ANDROGEN; TESTOSTERONE;

MUS;

EID: 44149100202     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.03.017     Document Type: Article

References (26)

1. Yoshiike N., Kaneda F., and Takimoto H. Epidemiology of obesity and public health strategies for its control in Japan. Asia Pac. J. Clin. Nutr. 11 Suppl. 8 (2002) S727-S731
2. Tsugane S., Sasaki S., and Tsubono Y. Under- and overweight impact on mortality among middle-aged Japanese men and women: a 10-y follow-up pf JPHC study cohort I. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 529-537
3. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III), Final Report, Circulation 106 (2002) 3143-3421.
4. Mauras N., Hayes V., Welch S., Rini A., Helgeson K., Dokler M., Veldhuis J.D., and Urban R.J. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. J. Clin. Endocrinol. Metab. 83 (1998) 1886-1992
5. Pasquali R. Obesity and androgens: facts and perspectives. Fertil. Steril. 85 (2006) 1319-1340
6. Vermeulen A. Andropause. Maturitas 34 (2000) 5-15
7. Kyle U.G., Genton L., Hans D., Karesgard L., Slosman D.O., and Pichard C. Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 19 and 94 years. Eur. J. Clin. Nutr. 55 (2001) 663-672
8. Rolf C., von Eckardstein S., Koken U., and Nieschlag E. Testosterone substitution of hypogonadal men prevents the age-dependent increases in body mass index, body fat and leptin seen in healthy ageing men: results of a cross-sectional study. Eur. J. Endocrinol. 146 (2002) 505-511
9. Wang C., Swedloff R.S., Iranmanesh A., Dobs A., Snyder P.J., Cunningham G., Matsumoto A.M., Weber T., and Berman N. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J. Clin. Endocrinol. Metab. 85 (2000) 2839-2853
10. Sato T., Matsumoto T., Yamada T., Watanabe T., Kawano H., and Kato S. Late onset of obesity in male androgen receptor-deficient (AR KO) mice. Biochem. Biophys. Res. Commun. 300 (2003) 167-171
11. Yeh S., Tsai M.Y., Xu Q., Mu X.M., Lardy H., Huang K.E., Lin H., Yeh S.D., Altuwaijri S., Zhou X., Xing L., Boyce B.F., Hung M.C., Zhang S., Gan L., and Chang C. Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13498-13503
12. Sato T., Matsumoto T., Kawano H., Watanabe T., Uematsu Y., Sekine K., Fukuda T., Aihara K., Krust A., Yamada T., and Kato S. Brain masculinization requires androgen receptor function. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 1673-1678
13. Kawano H., Sato T., Yamada T., Matsumoto T., Sekine K., Watanabe T., Nakamura T., Fukuda T., Yoshimura K., Yoshizawa T., and Kato S. Suppressive function of androgen receptor in bone resorption. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 9416-9421
14. Fan W., Yanase T., Nomura M., Okabe T., Goto K., Sato T., Kawano H., Kato S., and Nawata H. Androgen receptor null male mice develop late-onset obesity due to decreased energy expenditure and lypolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54 (2005) 1000-1008
15. Argyropoulos G., and Harper M.E. Uncoupling proteins and thermoregulation. J. Appl. Physiol. 92 (2002) 2187-2198
16. Bachman E.S., Dhillon H., Zhang C.Y., Cinti S., Bianco A.C., Kobilka B.K., and Lowell B.B. betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science 297 (2002) 843-845
17. Spiegelman B.M., and Flier J.S. Obesity and the regulation of energy balance. Cell 104 (2001) 531-543
18. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., Furuyama N., Kondo H., Takahashi M., Arita Y., Komuro R., Ouchi N., Kihara S., Tochino Y., Okutomi K., Horie M., Takeda S., Aoyama T., Funahashi T., and Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8 (2002) 731-737
19. Nishizawa H., Shimomura I., Kishida K., Maeda N., Kuriyama H., Nagaretani H., Matsuda M., Kondo H., Furuyama N., Kihara S., Nakamura T., Tochino Y., Funahashi T., and Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51 (2002) 2734-2741
20. Lanfranco F., Zitzmann M., Simoni M., and Nieschlag E. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clin. Endocrinol. (Oxf.) 60 (2004) 500-507
21. Xu A., Chan K.W., Hoo R.L., Wang Y., Tan K.C., Zhang J., Chen B., Lam M.C., Tse C., Cooper G.J., and Lam K.S. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J. Biol. Chem. 280 (2005) 18073-18080
22. Kubota N., Terauchi Y., Miki H., Tamemoto H., Yamauchi T., Komeda K., Satoh S., Nakano R., Ishii C., Sugiyama T., Eto K., Tsubamoto Y., Okuno A., Murakami K., Sekihara H., Hasegawa G., Naito M., Toyoshima Y., Tanaka S., Shiota K., Kitamura T., Fujita T., Ezaki O., Aizawa S., and Kadowaki T. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell 4 (1999) 597-609
23. Lin H.Y., Xu Q., Yeh S., Wang R.S., Sparks J.D., and Chang C. Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes 54 (2005) 1717-1725
24. Singh R., Artaza J.N., Taylor W.E., Braga M., Yuan X., Gonzalez-Cadavid N.F., and Bhasin S. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147 (2006) 141-154
25. Ross S.E., Hemati N., Longo K.A., Babett C.N., Jucas P.C., Erickson R.L., and MacDonald O.A. Inhibition of adipogenesis by Wnt signaling. Science 289 (2000) 950-953
26. Bhasin S., Cunningham G.R., Hayes F.J., Matsumoto A.M., Snyder P.J., Swerdloff R.S., and Montori V.M. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 91 (2006) 1995-2010